leadf
logo-loader
OTCQB:MMEDF

MindMed

Receive alerts
Market:
OTCQB
Market Cap:
$538.11 m
Price
1.65 USD
Change
4.43%
52 weeks high
1.98
52 weeks low
0.08

In brief

MindMed is a neuropharmaceutical drug development platform advancing medicines based on psychedelic substances through rigorous science and clinical trials. MindMed’s mission is to discover, develop and deploy psychedelic inspired medicines that alleviate suffering and improve health. MindMed is a unique drug development platform that seeks to prove the safety and efficacy of psychedelic-based substances as disruptive technologies and solutions for a continuum of mental illnesses and high unmet medical needs. These medical needs currently include addiction, anxiety, ADHD, and cluster headaches.

Snapshot

The New York City-based company has several projects in various stages from planning to ongoing clinical trials with a strong focus on legendary LSD